Gloria Melanie 4
4 · Immunovant, Inc. · Filed Jul 10, 2026
Research Summary
AI-generated summary of this filing
Immunovant (IMVT) COO Gloria Melanie Sells 2,036 Shares
What Happened Gloria Melanie, Chief Operating Officer of Immunovant (IMVT), sold a total of 2,036 shares on July 8, 2026 for aggregate proceeds of about $80,532. The sale consisted of 1,930 shares at a weighted-average price of $39.53 (proceeds $76,293) and 106 shares at a weighted-average price of $39.99 (proceeds $4,239). This was a sale (not a purchase) and was performed to cover tax withholding obligations related to RSU vesting, not an independent discretionary sale.
Key Details
- Transaction date: July 8, 2026 (Form 4 filed July 10, 2026—timely within the typical two-business-day window).
- Shares sold and prices:
- 1,930 shares disposed at weighted-average $39.53 (range reported 38.91–39.89 per footnote).
- 106 shares disposed at weighted-average $39.99 (range reported 39.92–40.03 per footnote).
- Total proceeds: approximately $80,532.
- Reason: Sell-to-cover tax withholding for RSUs granted April 1, 2025; 4,761 RSUs vested on July 1, 2026 (footnote states sale was mandatory to satisfy withholding and not discretionary).
- Disclosure note: Footnotes state the prices are weighted averages and that the Reporting Person will provide a breakdown of shares sold at each price upon request.
- Shares owned after the transaction: not specified in the provided excerpt of the filing—see the full Form 4 for post-transaction beneficial ownership.
Context: This was a routine sell-to-cover tied to vested RSUs (tax withholding), which is common and generally not interpreted as a statement about the insider’s view of the company.
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-07-08$39.53/sh−1,930$76,293→ 222,463 total - Sale
Common Stock
[F1][F3]2026-07-08$39.99/sh−106$4,239→ 222,357 total
Footnotes (3)
- [F1]On April 1, 2025, the holder was granted 76,181 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 3, 2025, of which 4,761 of these RSUs vested on July 1, 2026. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.91 - $39.89 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.92 - $40.03 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.